Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -126.84% is 135% below its 4-year average of -53.98%, around the middle of its 4-year range (-263.28%–-19.81%).
As of the fiscal period ended Tuesday, June 30, 2026. 74.59% below its 12-month average of -72.65%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -126.84%.
RETURN ON INVESTED CAPITAL (ROIC)
-126.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-72.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-75.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-74.59%
CURRENT VS 3Y AVG
-68.79%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 764 covered companies
CURRENT VS SECTOR MEDIAN
-268.33%
vs the sector median at left
Context Therapeutics Inc.
Market Cap
$29.50M
Return on Invested Capital (ROIC)
-126.84%
TTM Avg
-72.65%
3Y Avg
-75.14%
5Y Avg
N/A
Market Cap
$29.48M
Return on Invested Capital (ROIC)
-99.36%
TTM Avg
-324.14%
3Y Avg
-260.84%
5Y Avg
-230.57%
Market Cap
$30.34M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-54.98%
3Y Avg
-73.47%
5Y Avg
-75.57%
Market Cap
$29.33M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$29.95M
Return on Invested Capital (ROIC)
-42.23%
TTM Avg
-23.50%
3Y Avg
-191.16%
5Y Avg
-191.16%
Market Cap
$30.00M
Return on Invested Capital (ROIC)
-135.73%
TTM Avg
-98.73%
3Y Avg
-101.28%
5Y Avg
-89.83%
Market Cap
$31.12M
Return on Invested Capital (ROIC)
-115.18%
TTM Avg
-232.75%
3Y Avg
-220.13%
5Y Avg
-210.39%
Market Cap
$28.37M
Return on Invested Capital (ROIC)
-109.29%
TTM Avg
-89.70%
3Y Avg
-72.19%
5Y Avg
-61.37%
Market Cap
$30.97M
Return on Invested Capital (ROIC)
-32.68%
TTM Avg
-38.21%
3Y Avg
-33.48%
5Y Avg
-43.06%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | $29.50M | -126.84% | -72.65% | -75.14% | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.48M | -99.36% | -324.14% | -260.84% | -230.57% |
| BeyondSpring Inc. (BYSI)vs › | $30.34M | N/A | -54.98% | -73.47% | -75.57% |
| OneMedNet Corporation (ONMD)vs › | $29.33M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.95M | -42.23% | -23.50% | -191.16% | -191.16% |
| CervoMed Inc. (CRVO)vs › | $30.00M | -135.73% | -98.73% | -101.28% | -89.83% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.12M | -115.18% | -232.75% | -220.13% | -210.39% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.37M | -109.29% | -89.70% | -72.19% | -61.37% |
| SCYNEXIS, Inc. (SCYX)vs › | $30.97M | -32.68% | -38.21% | -33.48% | -43.06% |
| InspireMD, Inc. (NSPR)vs › | $26.23M | -153.04% | -84.65% | -78.92% | -71.84% |
ROIC
-126.8%
ROE
-120.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -126.84% |
| 2026-03-31 | -83.17% |
| 2025-12-31 | -65.65% |
| 2025-09-30 | -41.20% |
| 2025-06-30 | -46.37% |
| 2025-03-31 | -34.73% |
| 2024-12-31 | -31.37% |
| 2024-09-30 | -38.75% |
| 2024-06-30 | -19.81% |
| 2024-03-31 | -263.28% |
| 2023-12-31 | -211.21% |
| 2023-09-30 | -119.78% |
| 2023-06-30 | -82.86% |
| 2023-03-31 | -64.75% |
| 2022-12-31 | -44.25% |
| 2022-09-30 | -38.32% |
| 2022-06-30 | -29.07% |
| 2022-03-31 | -28.90% |
| 2021-12-31 | -21.81% |
